Inflammasomes and their role in innate immunity of sexually transmitted infections

Frontiers in Immunology

Volumn 7, Issue DEC, 2016, Pages

  Verma, Vivek ^a   Dhanda, Rakesh Singh ^b   Møller, Niels Frimodt ^c   Yadav, Manisha ^a,c  

^a UNIVERSITY OF DELHI   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^c University of Copenhagen   (Denmark)

Author keywords

Host defense; Inflammasomes; Innate immunity; NOD like receptors; Pathogens; Sexually transmitted infections

Indexed keywords

CASPASE 8; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; REACTIVE OXYGEN METABOLITE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ATHEROSCLEROSIS; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DNA POLYMORPHISM; GENETIC CODE; GENITAL HERPES; GONORRHEA; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFLAMMATION; INNATE IMMUNITY; METABOLIC DISORDER; MICROBIAL DIVERSITY; MORTALITY; NONHUMAN; PNEUMONIA; PYROPTOSIS; REVIEW; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; ULCUS MOLLE; UPREGULATION; URINARY TRACT INFECTION; WART VIRUS;

EID: 85009414615     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00540     Document Type: Review

References (91)

1. Medzhitov R. Origin and physiological roles of inflammation. Nature (2008) 454(7203):428-35. doi:10.1038/nature07201
2. Jones JD, Dangl JL. The plant immune system. Nature (2006) 444(7117):323-9. doi:10.1038/nature05286
3. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol (2009) 27:229-65. doi:10.1146/annurev.immunol.021908.132715
4. Boyden ED, Dietrich WF. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet (2006) 38(2):240-4. doi:10.1038/ng1724
5. Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM, Ojcius DM. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem (2007) 282(5):2871-9. doi:10.1074/jbc.M608083200
6. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol (2008) 9(8):847-56. doi:10.1038/ni.1631
7. Hentze H, Lin XY, Choi MS, Porter AG. Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin. Cell Death Differ (2003) 10(9):956-68. doi:10.1038/sj.cdd.4401264
8. Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science (2008) 320(5876):674-7. doi:10.1126/science.1156995
9. Zhao Y, Yang J, Shi J, Gong YN, Lu Q, Xu H, et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature (2011) 477(7366):596-600. doi:10.1038/nature10510
10. Bürckstümmer T, Baumann C, Blüml S, Dixit E, Dürnberger G, Jahn H, et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol (2009) 10(3):266-72. doi:10.1038/ni.1702
11. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol (2010) 11(11):997-1004. doi:10.1038/ni.1932
12. Schroder K, Tschopp J. The inflammasomes. Cell (2010) 140(6):821-32. doi:10.1016/j.cell.2010.01.040
13. Henao-Mejia J, Elinav E, Strowig T, Flavell RA. Inflammasomes: far beyond inflammation. Nat Immunol (2012) 13(4):321-4. doi:10.1038/ni.2257
14. Franchi L, Eigenbrod T, Nunez G. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol (2009) 183(2):792-6. doi:10.4049/jimmunol.0900173
15. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol (2009) 183(2):787-91. doi:10.4049/jimmunol.0901363
16. Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature (2013) 493(7434):674-8. doi:10.1038/nature11729
17. WHO. Global Strategy for the Prevention and Control of Sexually Transmitted Infections: 2006-2015: Breaking the Chain of Transmission. Geneva: World Health Organization (2007).
18. WHO. Global Prevalence and Incidence of Curable STIs. Geneva: World Health Organization (WHO/CDS/CDR/EDC/2001.10) (2001).
19. Mayaud P, Mabey D. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sex Transm Infect (2004) 80(3):174-82. doi:10.1136/sti.2002.004101
20. Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health (2004) 36(1):11-9. doi:10.1363/3601104
21. Sorce S, Krause KH. NOX enzymes in the central nervous system: from signaling to disease. Antioxid Redox Signal (2009) 11(10):2481-504. doi:10.1089/ARS.2009.2578
22. Hybiske K, Stephens RS. Mechanisms of Chlamydia trachomatis entry into nonphagocytic cells. Infect Immun (2007) 75(8):3925-34. doi:10.1128/IAI.00106-07
23. Byrne GI, Ojcius DM. Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol (2004) 2(10):802-8. doi:10.1038/nrmicro1007
24. Betts HJ, Wolf K, Fields KA. Effector protein modulation of host cells: examples in the Chlamydia spp. arsenal. Curr Opin Microbiol (2009) 12(1):81-7. doi:10.1016/j.mib.2008.11.009
25. Valdivia RH. Chlamydia effector proteins and new insights into chlamydial cellular microbiology. Curr Opin Microbiol (2008) 11(1):53-9. doi:10.1016/j.mib.2008.01.003
26. Barteneva N, Theodor I, Peterson EM, de la Maza LM. Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection. Infect Immun (1996) 64(11):4830-3.
27. Gervassi A, Alderson MR, Suchland R, Maisonneuve JF, Grabstein KH, Probst P. Differential regulation of inflammatory cytokine secretion by human dendritic cells upon Chlamydia trachomatis infection. Infect Immun (2004) 72(12):7231-9. doi:10.1128/IAI.72.12.7231-7239.2004
28. Lu H, Shen C, Brunham RC. Chlamydia trachomatis infection of epithelial cells induces the activation of caspase-1 and release of mature IL-18. J Immunol (2000) 165(3):1463-9. doi:10.4049/jimmunol.165.3.1463
29. Abdul-Sater AA, Koo E, Häcker G, Ojcius DM. Inflammasome-dependent caspase-1 activation in cervical epithelial cells stimulates growth of the intracellular pathogen Chlamydia trachomatis. J Biol Chem (2009) 284(39):26789-96. doi:10.1074/jbc.M109.026823
30. Abdul-Sater AA, Saïd-Sadier N, Padilla EV, Ojcius DM. Chlamydial infection of monocytes stimulates IL-1beta secretion through activation of the NLRP3 inflammasome. Microbes Infect (2010) 12(8-9):652-61. doi:10.1016/j.micinf.2010.04.008
31. Finethy R, Jorgensen I, Haldar AK, de Zoete MR, Strowig T, Flavell RA, et al. Guanylate binding proteins enable rapid activation of canonical and noncanonical inflammasomes in Chlamydia-infected macrophages. Infect Immun (2015) 83(12):4740-9. doi:10.1128/IAI.00856-15
32. Nagarajan UM, Sikes JD, Yeruva L, Prantner D. Significant role of IL-1 signaling, but limited role of inflammasome activation, in oviduct pathology during Chlamydia muridarum genital infection. J Immunol (2012) 188(6):2866-75. doi:10.4049/jimmunol.1103461
33. Itoh R, Murakami I, Chou B, Ishii K, Soejima T, Suzuki T, et al. Chlamydia pneumoniae harness host NLRP3 inflammasome-mediated caspase-1 activation for optimal intracellular growth in murine macrophages. Biochem Biophys Res Commun (2014) 452(3):689-94. doi:10.1016/j.bbrc.2014.08.128
34. Sorrentino R, Yilmaz A, Schubert K, Crother TR, Pinto A, Shimada K, et al. A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice. Cell Immunol (2015) 294(1):25-32. doi:10.1016/j.cellimm.2015.01.007
35. Cao W, Zou Y, Su S, He Z, Liu Y, Huang Q, et al. Chlamydial plasmid-encoded protein pORF5 induces production of IL-1beta and IL-18 via NALP3 inflammasome activation and p38 MAPK pathway. Int J Clin Exp Med (2015) 8(11):20368-79.
36. Kavathas PB, Boeras CM, Mulla MJ, Abrahams VM. Nod1, but not the ASC inflammasome, contributes to induction of IL-1beta secretion in human trophoblasts after sensing of Chlamydia trachomatis. Mucosal Immunol (2013) 6(2):235-43. doi:10.1038/mi.2012.63
37. Shimada K, Crother TR, Karlin J, Chen S, Chiba N, Ramanujan VK, et al. Caspase-1 dependent IL-1beta secretion is critical for host defense in a mouse model of Chlamydia pneumoniae lung infection. PLoS One (2011) 6(6):e21477. doi:10.1371/journal.pone.0021477
38. Omosun Y, McKeithen D, Ryans K, Kibakaya C, Blas-Machado U, Li D, et al. Interleukin-10 modulates antigen presentation by dendritic cells through regulation of NLRP3 inflammasome assembly during Chlamydia infection. Infect Immun (2015) 83(12):4662-72. doi:10.1128/IAI.00993-15
39. Greenhill CJ, Jones GW, Nowell MA, Newton Z, Harvey AK, Moideen AN, et al. Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction. Arthritis Res Ther (2014) 16(4):419. doi:10.1186/s13075-014-0419-y
40. Gurung P, Li B, Subbarao Malireddi RK, Lamkanfi M, Geiger TL, Kanneganti TD. Chronic TLR stimulation controls NLRP3 inflammasome activation through IL-10 mediated regulation of NLRP3 expression and caspase-8 activation. Sci Rep (2015) 5:14488. doi:10.1038/srep14488
41. Cheng W, Shivshankar P, Li Z, Chen L, Yeh IT, Zhong G. Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect Immun (2008) 76(2):515-22. doi:10.1128/IAI.01064-07
42. Joly S, Ma N, Sadler JJ, Soll DR, Cassel SL, Sutterwala FS. Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J Immunol (2009) 183(6):3578-81. doi:10.4049/jimmunol.0901323
43. Tomalka J, Ganesan S, Azodi E, Patel K, Majmudar P, Hall BA, et al. A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathog (2011) 7(12):e1002379. doi:10.1371/journal.ppat.1002379
44. Pietrella D, Pandey N, Gabrielli E, Pericolini E, Perito S, Kasper L, et al. Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome. Eur J Immunol (2013) 43(3):679-92. doi:10.1002/eji.201242691
45. Guo H, Gao J, Taxman DJ, Ting JP, Su L. HIV-1 infection induces interleukin-1beta production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes. J Biol Chem (2014) 289(31):21716-26. doi:10.1074/jbc.M114.566620
46. Reinholz M, Kawakami Y, Salzer S, Kreuter A, Dombrowski Y, Koglin S, et al. HPV16 activates the AIM2 inflammasome in keratinocytes. Arch Dermatol Res (2013) 305(8):723-32. doi:10.1007/s00403-013-1375-0
47. Gram AM, Frenkel J, Ressing ME. Inflammasomes and viruses: cellular defence versus viral offence. J Gen Virol (2012) 93(10):2063-75. doi:10.1099/vir.0.042978-0
48. Li W, Katz BP, Bauer ME, Spinola SM. Haemophilus ducreyi infection induces activation of the NLRP3 inflammasome in nonpolarized but not in polarized human macrophages. Infect Immun (2013) 81(8):2997-3008. doi:10.1128/IAI.00354-13
49. Duncan JA, Gao X, Huang MT, O'Connor BP, Thomas CE, Willingham SB, et al. Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J Immunol (2009) 182(10):6460-9. doi:10.4049/jimmunol.0802696
50. Babolin C, Amedei A, Ozolins D, Zilevica A, D'Elios MM, de Bernard M. TpF1 from Treponema pallidum activates inflammasome and promotes the development of regulatory T cells. J Immunol (2011) 187(3):1377-84. doi:10.4049/jimmunol.1100615
51. Dimopoulos G, Karabinis A, Samonis G, Falagas ME. Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study. Eur J Clin Microbiol Infect Dis (2007) 26(6):377-84. doi:10.1007/s10096-007-0316-2
52. Chaffin WL, López-Ribot JL, Casanova M, Gozalbo D, Martínez JP. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev (1998) 62(1):130-80.
53. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschläger N, Endres S, et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature (2009) 459(7245):433-6. doi:10.1038/nature07965
54. van de Veerdonk FL, Joosten LA, Devesa I, Mora-Montes HM, Kanneganti TD, Dinarello CA, et al. Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1β production by the fungal pathogen Candida albicans. J Infect Dis (2009) 199(7):1087-96. doi:10.1086/597274
55. Cheng SC, van de Veerdonk FL, Lenardon M, Stoffels M, Plantinga T, Smeekens S, et al. The dectin-1/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans. J Leukoc Biol (2011) 90(2):357-66. doi:10.1189/jlb.1210702
56. Gringhuis SI, Kaptein TM, Wevers BA, Theelen B, van der Vlist M, Boekhout T, et al. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1beta via a noncanonical caspase-8 inflammasome. Nat Immunol (2012) 13(3):246-54. doi:10.1038/ni.2222
57. van de Veerdonk FL, Joosten LA, Shaw PJ, Smeekens SP, Malireddi RK, van der Meer JW, et al. The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis. Eur J Immunol (2011) 41(8):2260-8. doi:10.1002/eji.201041226
58. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, et al. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe (2009) 5(5):487-97. doi:10.1016/j.chom.2009.05.002
59. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2. J Exp Med (2003) 197(9):1107-17. doi:10.1084/jem.20021787
60. Gross O, Gewies A, Finger K, Schäfer M, Sparwasser T, Peschel C, et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature (2006) 442(7103):651-6. doi:10.1038/nature04926
61. Whitney PG, Bär E, Osorio F, Rogers NC, Schraml BU, Deddouche S, et al. Syk signaling in dendritic cells orchestrates innate resistance to systemic fungal infection. PLoS Pathog (2014) 10(7):e1004276. doi:10.1371/journal.ppat.1004276
62. Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol (2013) 13(6):397-411. doi:10.1038/nri3452
63. Bruno VM, Shetty AC, Yano J, Fidel PL Jr, Noverr MC, Peters BM. Transcriptomic analysis of vulvovaginal candidiasis identifies a role for the NLRP3 inflammasome. MBio (2015) 6(2):e182-215. doi:10.1128/mBio.00182-15
64. Gabrielli E, Pericolini E, Luciano E, Sabbatini S, Roselletti E, Perito S, et al. Induction of caspase-11 by aspartyl proteinases of Candida albicans and implication in promoting inflammatory response. Infect Immun (2015) 83(5):1940-8. doi:10.1128/IAI.02895-14
65. Bendel CM, Hess DJ, Garni RM, Henry-Stanley M, Wells CL. Comparative virulence of Candida albicans yeast and filamentous forms in orally and intravenously inoculated mice. Crit Care Med (2003) 31(2):501-7. doi:10.1097/01.CCM.0000049954.48239.A1
66. Wellington M, Koselny K, Krysan DJ. Candida albicans morphogenesis is not required for macrophage interleukin 1beta production. MBio (2012) 4(1):e412-33. doi:10.1128/mBio.00433-12
67. Borghi M, De Luca A, Puccetti M, Jaeger M, Mencacci A, Oikonomou V, et al. Pathogenic NLRP3 inflammasome activity during Candida infection is negatively regulated by IL-22 via activation of NLRC4 and IL-1Ra. Cell Host Microbe (2015) 18(2):198-209. doi:10.1016/j.chom.2015.07.004
68. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med (2011) 62:141-55. doi:10.1146/annurev-med-042909-093756
69. Nixon DE, Landay AL. Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS (2010) 5(6):498-503. doi:10.1097/COH.0b013e32833ed6f4
70. UNAIDS. Understanding UNAIDS HIV Data and Estimates. Geneva: WHO (2016).
71. Pontillo A, Brandão LA, Guimarães RL, Segat L, Athanasakis E, Crovella S. A 3'UTR SNP in NLRP3 gene is associated with susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr (2010) 54(3):236-40. doi:10.1097/QAI.0b013e3181dd17d4
72. Nasi M, De Biasi S, Bianchini E, Digaetano M, Pinti M, Gibellini L, et al. Analysis of inflammasomes and antiviral sensing components reveals decreased expression of NLRX1 in HIV-positive patients assuming efficient antiretroviral therapy. AIDS (2015) 29(15):1937-41. doi:10.1097/QAD.0000000000000830
73. Pontillo A, Silva LT, Oshiro TM, Finazzo C, Crovella S, Duarte AJ, et al. HIV-1 induces NALP3-inflammasome expression and interleukin-1beta secretion in dendritic cells from healthy individuals but not from HIV-positive patients. AIDS (2012) 26(1):11-8. doi:10.1097/QAD.0b013e32834d697f
74. Chattergoon MA, Latanich R, Quinn J, Winter ME, Buckheit RW III, Blankson JN, et al. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal toll-like receptors without induction of type 1 interferon. PLoS Pathog (2014) 10(5):e1004082. doi:10.1371/journal.ppat.1004082
75. Thomas C. Roadblocks in HIV research: five questions. Nat Med (2009) 15(8):855-9. doi:10.1038/nm0809-855
76. Galloway NL, Doitsh G, Monroe KM, Yang Z, Muñoz-Arias I, Levy DN, et al. Cell-to-cell transmission of HIV-1 is required to trigger pyroptotic death of lymphoid tissue-derived CD4 T cells. Cell Rep (2015) 12(10):1555-63. doi:10.1016/j.celrep.2015.08.011
77. Lou Y, Qesmi R, Wang Q, Steben M, Wu J, Heffernan JM. Epidemiological impact of a genital herpes type 2 vaccine for young females. PLoS One (2012) 7(10):e46027. doi:10.1371/journal.pone.0046027
78. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology (2010) 401(1):70-9. doi:10.1016/j.virol.2010.02.002
79. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine (2006) 24(Suppl 3):S3/35-41. doi:10.1016/j.vaccine.2006.06.015
80. Tapsall JW. Antibiotic resistance in Neisseria gonorrhoeae. Clin Infect Dis (2005) 41(Suppl 4):S263-8. doi:10.1086/430787
81. Fichorova RN, Desai PJ, Gibson FC III, Genco CA. Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect Immun (2001) 69(9):5840-8. doi:10.1128/IAI.69.9.5840-5848.2001
82. Harvey HA, Post DM, Apicella MA. Immortalization of human urethral epithelial cells: a model for the study of the pathogenesis of and the inflammatory cytokine response to Neisseria gonorrhoeae infection. Infect Immun (2002) 70(10):5808-15. doi:10.1128/IAI.70.10.5808-5815.2002
83. Zhou X, Gao X, Broglie PM, Kebaier C, Anderson JE, Thom N, et al. Hexa-acylated lipid A is required for host inflammatory response to Neisseria gonorrhoeae in experimental gonorrhea. Infect Immun (2014) 82(1):184-92. doi:10.1128/IAI.00890-13
84. Hughes FM Jr, Vivar NP, Kennis JG, Pratt-Thomas JD, Lowe DW, Shaner BE, et al. Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation. Am J Physiol Renal Physiol (2014) 306(3):F299-308. doi:10.1152/ajprenal.00297.2013
85. Wang C, Mendonsa GR, Symington JW, Zhang Q, Cadwell K, Virgin HW, et al. Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo. Proc Natl Acad Sci U S A (2012) 109(27):11008-13. doi:10.1073/pnas.1203952109
86. Schaale K, Peters KM, Murthy AM, Fritzsche AK, Phan MD, Totsika M, et al. Strain-and host species-specific inflammasome activation, IL-1beta release, and cell death in macrophages infected with uropathogenic Escherichia coli. Mucosal Immunol (2016) 9(1):124-36. doi:10.1038/mi.2015.44
87. Yang HH, Jun HK, Jung YJ, Choi BK. Enterococcus faecalis activates caspase-1 leading to increased interleukin-1 beta secretion in macrophages. J Endod (2014) 40(10):1587-92. doi:10.1016/j.joen.2014.06.015
88. Willingham SB, Allen IC, Bergstralh DT, Brickey WJ, Huang MT, Taxman DJ, et al. NLRP3 (NALP3, cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and-independent pathways. J Immunol (2009) 183(3):2008-15. doi:10.4049/jimmunol.0900138
89. Cai S, Batra S, Wakamatsu N, Pacher P, Jeyaseelan S. NLRC4 inflammasome-mediated production of IL-1beta modulates mucosal immunity in the lung against Gram-negative bacterial infection. J Immunol (2012) 188(11):5623-35. doi:10.4049/jimmunol.1200195
90. Nagamatsu K, Hannan TJ, Guest RL, Kostakioti M, Hadjifrangiskou M, Binkley J, et al. Dysregulation of Escherichia coli alpha-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc Natl Acad Sci U S A (2015) 112(8):E871-80. doi:10.1073/pnas.1500374112
91. Craven RR, Gao X, Allen IC, Gris D, Bubeck Wardenburg J, McElvania-Tekippe E, et al. Staphylococcus aureus α-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS One (2009) 4(10):e7446. doi:10.1371/journal.pone.0007446